Sunday, May 12, 2024

Why Big Pharma is Investing Billions in This Biotech

 

Monument Traders Alliance Alerts

We have a message from Samantha Tino at Behind the Markets. The message that Samantha relayed to her readers is very interesting, and we wanted to share it with you.

- Ryan Fitzwater, Publisher


Why Big Pharma is Investing Billions in This Biotech

Dear Reader,

If you're on the hunt for a great biotech stock under $20... you need to see this video.

This tiny biotech has achieved something remarkable. They're revolutionizing healthcare with a radical treatment that could help as many as 50 million people... and save the U.S. $20 trillion in medical costs.

Here's the deal: this company figured out how to use a "Drug Smuggler" to help treat Alzheimer's and Parkinson's.

This is HUGE.

Right now, Big Pharma sells $16 billion worth of Alzheimer's drugs that don't even make it to the brain!

But now, this company is developing a platform that could allow for the cure of nearly all neurodegenerative diseases - like Alzheimer's, Parkinson's, and ALS.

The Economist says this would be a "boon to humanity."

Even Jeff Bezos has invested $130 million into this company.

We are witnessing a key moment in medical history...

And this tiny biotech is leading the charge.

Big Phamra giants are already pouring money into this stock. For instance:

  • Biogen invested $1 billion...
  • Sanofi invested $125 million...
  • Japanese Big Pharma giant Takeda invested $150 million.

Despite these huge partnerships, the company I'm talking about is still an underpriced micro-cap.

These investments could catapult the stock to new heights in the near future...

So if you want the chance to own the next big thing in biotech...

Watch my exclusive report here>>>

 

Sincerely,

Samantha Tino,
Editor
Behind the Markets

 

No comments:

Post a Comment

Your Weekly Recommended Reads

Powered by AI, personalised for you Catch up on key news and analysis from the week gone by with The Business of Fashion's My...